Dr. Sara Vande Walle

Creative & Driven Pharm.D. with a passion for Managed Care Pharmacy! Managed Care Pharmacy Resident at Prime Therapeutics @Prime_PBM @AMCPorg @UMN_Pharmacy

[Dr. Sara Vande Walle @pharmacyfocus]

Read about my #managedcare #residency experience at Prime Therapeutics, what got me there, and why I'm excited about what's next: https://t.co/DjWmdpc3i9

[Prime Therapeutics @Prime_PBM]

Meet Sara Vande Walle, PharmD, Prime's current Managed Care Pharmacy Resident. Learn why Prime's a great place to launch your pharmacy career: https://t.co/80Jxxo11bU
@UMN_Pharmacy @AMCPorg

[Dr. Sara Vande Walle @pharmacyfocus]

FDA approves @Shireplc's Takhzyro (lanadelumab-flyo), for hereditary angioedema (HAE) prophylaxis, the first mAB for HAE https://t.co/kGO3mnHubp #Shire #HAE #hereditaryangioedema #raredisease #newdrug #lanadelumab #Takhzyro #managedcare #pharmacist #FDA

[Dr. Sara Vande Walle @pharmacyfocus]

FDA approves Amicus Therapeutics' $FOLD Galafold (migalastat) for adults with amenable Fabry disease mutations. https://t.co/ySaBG2afO3 #FDA #Amicus #migalastat #Galafold #Fabrydisease #raredisease #pharmacist #managedcare #drugapproval #newdrug #newdrugapproval

[Dr. Sara Vande Walle @pharmacyfocus]

Pharmacogenomics on the rise: GSK partners with 23andMe in 4-year deal in hopes to use their extensive genomic database to drive drug discovery. #pharmacogenomics #drugdiscovery
#genetics #genomics #23andMe #GSK  https://t.co/frxflLcsPo

[Dr. Sara Vande Walle @pharmacyfocus]

AbbVie's ORILISSA (elagolix) receives FDA approval for treatment of endometriosis pain. #newdrug #drug #approved #FDA #AbbVie #elagolix #endometriosis #drugapprovals https://t.co/Dlc1Vnxisf

[CNN Breaking News @cnnbrk]

For the first time, the US Food and Drug Administration approves a cannabis-based drug. Epidiolex treats two types of epileptic syndromes. https://t.co/zuiA0FlBEJ

[Dr. Sara Vande Walle @pharmacyfocus]

FDA approves Mylan and Biocon's Fulphila, the first biosimilar to Amgen's Neulasta. https://t.co/0YD2BJkSLZ #fulphila #neulasta #biosimilar #FDA #FDAapproved #drugs #newdrug #newdrugapproval #Mylan

[Dr. Sara Vande Walle @pharmacyfocus]

APPROVED: Amgen's new migraine prevention drug Aimovig approved by FDA, will cost $6900 per year https://t.co/mDRSEAVqi3 #migraine #fda #newdrug #aimovig #amgen #pharma

[Prime Therapeutics @Prime_PBM]

We’re proud to have 5 posters at #ACMP2018! Here’s Dr. Sara Vande Walle with her poster on the study she co-authored that identified the high cost of treatment for hereditary angioedema (HAE):https://t.co/Gqtq8YNu38

[Dr. Sara Vande Walle @pharmacyfocus]

@JohnCarreyrou @medicalmomentum

[Dr. Sara Vande Walle @pharmacyfocus]

@SpecialtyPTimes recently published three articles featuring @Prime_PBM research presented at the AMCP 2018 Annual meeting including my work on HAE: https://t.co/mRrV1dZBUJ and my colleagues' work on hemophilia: https://t.co/xzqC5QtpJJ and MS: https://t.co/0cnNZGds3t

[Prime Therapeutics @Prime_PBM]

We’re at #AMCP2018 next week, are you? Our top researchers will present 5 new posters. Learn more: https://t.co/sgwGkHys5K

[Dr. Sara Vande Walle @pharmacyfocus]

FDA approves Ultragenyx's Crysvita (burosumab) for X-linked hypophosphatemia https://t.co/3v4O39p7Fa #FDA #drug #drugapproval #orphandrug #drugprices #raredisease #ultragenyx #burosumab #Crysvita

[Dr. Sara Vande Walle @pharmacyfocus]

Sun Pharma gets FDA approval for its plaque psoriasis biologic, Ilumya. https://t.co/bWW2jGUHoQ #FDA #approved #drugapproval #newdrug #biologics #psoriasis #Ilumya #SunPharma

[Dr. Sara Vande Walle @pharmacyfocus]

@gzil Congratulations in advance! Your bride is beautiful! :)

[Prime Therapeutics @Prime_PBM]

Were you at sPCMA Business Forum conference this week? Prime's Steve Johnson, AVP, Health Outcomes and Rae McMahan, VP & General Mgr, Enterprise Specialty led a discussion on how Prime uses data to develop programs to help manage the costs of new specialty drugs.

[Dr. Sara Vande Walle @pharmacyfocus]

@Cigna $CI to buy @ExpressScripts $ESRX for more than $50 Billion in major health care deal https://t.co/nx7llDxZU8 #Cigna #ExpressScripts #ESI #PBM

[Dr. Sara Vande Walle @pharmacyfocus]

#APPROVED: #FDA approves @Theratech_Inc's new HIV salvage therapy, first #mAb for #HIV, #Trogarzo. https://t.co/eeER7UdhtC #newdrug #drugapproval #ibalizumab #drugs

[Prime Therapeutics @Prime_PBM]

Will you be attending #PBMI2018 next week? Be sure and look for our own Dr. Cathy Starner, PharmD, BCPS, Health Outcomes Consultant Sr. Principal. She will be speaking on Opioid Managed Care Pharmacy Programs: What Can Be Done and How, at the conference on Tues. #Opioid @The_PBMI

[Dr. Sara Vande Walle @pharmacyfocus]

Had a great afternoon with @amcporg @UMN_Pharmacy chapter students visiting us at @Prime_PBM to hear about career opportunities for pharmacists in our organization! #amcp #umnpharmacy #primetherapeutics #PBM #managedcare #managedcarepharmacy #pharmacystudent #pharmacyleaders

[Dr. Sara Vande Walle @pharmacyfocus]

Excited to have #pharmacy #students from @UMN_Pharmacy @amcporg chapter come for a site visit to @Prime_PBM this Friday to hear about different career opportunities in managed care! #managedcare #managedcarepharmacy #career #primetherapeutics #amcp